Heparin prodrugs and drug delivery stents formed therefrom
    12.
    发明授权
    Heparin prodrugs and drug delivery stents formed therefrom 失效
    肝素前药和由其形成的药物递送支架

    公开(公告)号:US07563780B1

    公开(公告)日:2009-07-21

    申请号:US10871658

    申请日:2004-06-18

    Abstract: A prodrug comprising a heparin and a drug is provided. The prodrug can be used to form a coating on a medical device. The prodrug can also be used with a polymeric material to form a coating on a medical device. The polymeric material can be a hydrophobic polymer, a hydrophilic polymer, a non-fouling polymer, or combinations thereof. The medical device can be implanted in a human being for the treatment of a disease such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof.

    Abstract translation: 提供了包含肝素和药物的前药。 前药可用于在医疗装置上形成涂层。 前药还可以与聚合物材料一起使用以在医疗装置上形成涂层。 聚合物材料可以是疏水性聚合物,亲水性聚合物,非结垢聚合物,或其组合。 医疗器械可以植入人类用于治疗动脉粥样硬化,血栓形成,再狭窄,出血,血管解剖或穿孔,血管动脉瘤,易损斑块,慢性完全闭塞,跛行,静脉和人造移植物的吻合增殖等疾病 ,胆管阻塞,输尿管阻塞,肿瘤阻塞或其组合。

    Heparin prodrugs and drug delivery stents formed therefrom
    14.
    发明授权
    Heparin prodrugs and drug delivery stents formed therefrom 有权
    肝素前药和由其形成的药物递送支架

    公开(公告)号:US07396541B2

    公开(公告)日:2008-07-08

    申请号:US11228420

    申请日:2005-09-15

    Abstract: A prodrug comprising a heparin and a drug is provided. The prodrug can be used to form a coating on a medical device. The prodrug can also be used with a polymeric material to form a coating on a medical device. The polymeric material can be a hydrophobic polymer, a hydrophilic polymer, a non-fouling polymer, or combinations thereof. The medical device can be implanted in a human being for the treatment of a disease such as atherosclerosis, thrombosis, restenosis, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, or combinations thereof.

    Abstract translation: 提供了包含肝素和药物的前药。 前药可用于在医疗装置上形成涂层。 前药还可以与聚合物材料一起使用以在医疗装置上形成涂层。 聚合物材料可以是疏水性聚合物,亲水性聚合物,非结垢聚合物,或其组合。 医疗器械可以植入人类用于治疗动脉粥样硬化,血栓形成,再狭窄,出血,血管解剖或穿孔,血管动脉瘤,易损斑块,慢性完全闭塞,跛行,静脉和人造移植物的吻合增殖等疾病 ,胆管阻塞,输尿管阻塞,肿瘤阻塞或其组合。

    MEDICAL DEVICE WITH POROUS SURFACE FOR CONTROLLED DRUG RELEASE AND METHOD OF MAKING THE SAME
    15.
    发明申请
    MEDICAL DEVICE WITH POROUS SURFACE FOR CONTROLLED DRUG RELEASE AND METHOD OF MAKING THE SAME 有权
    用于控制药物释放的多孔表面的医疗装置及其制造方法

    公开(公告)号:US20070299509A1

    公开(公告)日:2007-12-27

    申请号:US11851675

    申请日:2007-09-07

    Applicant: Ni DING

    Inventor: Ni DING

    Abstract: The medical devices of the invention comprise a portion having a porous surface for release of at least one biologically active agent therefrom. The porous surface is made of a material such as a polymer having a plurality of voids. To load the porous surface with a biologically active agent or drug, an electrophoresis method is employed. In this method, a device having a porous surface is placed into a drug solution or suspension, along with an electrode. An electric current is applied to the device and electrode. Under such a current, the drug, which has a positive or negative charge, will be loaded into the pores or voids of the porous surface.

    Abstract translation: 本发明的医疗装置包括具有用于从其释放至少一种生物活性剂的多孔表面的部分。 多孔表面由诸如具有多个空隙的聚合物的材料制成。 为了用生物活性剂或药物加载多孔表面,使用电泳方法。 在该方法中,具有多孔表面的装置与电极一起放入药液或悬浮液中。 电流被施加到器件和电极上。 在这样的电流下,具有正电荷或负电荷的药物将被加载到多孔表面的孔或空隙中。

    Fluid treatment of a polymeric coating on an implantable medical device
    17.
    发明授权
    Fluid treatment of a polymeric coating on an implantable medical device 有权
    在可植入医疗设备上的聚合物涂层的流体处理

    公开(公告)号:US07285304B1

    公开(公告)日:2007-10-23

    申请号:US10603889

    申请日:2003-06-25

    CPC classification number: A61L31/10 A61F2/91 A61F2210/0004 Y10S623/901

    Abstract: A method of manufacturing an implantable medical device including applying a composition to an implantable medical device, the composition including a polymer, an active agent and a solvent; allowing the solvent to evaporate to form a dry coating, the dry coating comprising less than about 2% residual fluid content (w/w); applying a fluid to the dry coating, the fluid being substantially free from any polymer; and allowing the fluid to evaporate from the coating.

    Abstract translation: 一种制造可植入医疗装置的方法,包括将组合物施用于可植入医疗装置,所述组合物包括聚合物,活性剂和溶剂; 允许溶剂蒸发以形成干燥涂层,干涂层包含小于约2%的残留流体含量(w / w); 将流体施加到干燥涂层,所述流体基本上不含任何聚合物; 并允许流体从涂层蒸发。

    Therapeutic composition and a method of coating implantable medical devices
    18.
    发明申请
    Therapeutic composition and a method of coating implantable medical devices 审中-公开
    治疗组合物和可植入医疗器械的涂敷方法

    公开(公告)号:US20060073183A1

    公开(公告)日:2006-04-06

    申请号:US11282849

    申请日:2005-11-17

    Applicant: Ni Ding

    Inventor: Ni Ding

    Abstract: A therapeutic composition is provided including a polysaccharide or a cationic peptide dissolved in an organic substance. The polysaccharide can be heparin or a derivative of heparin. The cationic peptide can be L-arginine, oligo-L-arginine or poly-L-arginine. The organic substance can be formamide. A method of coating an implantable medical device is also provided, comprising applying the therapeutic composition to the device and allowing the organic substance to evaporate. The device can be a stent.

    Abstract translation: 提供了包含溶解在有机物质中的多糖或阳离子肽的治疗组合物。 多糖可以是肝素或肝素的衍生物。 阳离子肽可以是L-精氨酸,寡聚-L-精氨酸或聚-L-精氨酸。 有机物可以是甲酰胺。 还提供了涂覆可植入医疗装置的方法,包括将该治疗组合物施用于该装置并允许有机物质蒸发。 该装置可以是支架。

Patent Agency Ranking